WaveMan · Form 4
Rtw Investments, LP insider trades
> Search tickers & screens ⌘K
LIVE

Rtw Investments, LP insider trades

Rtw Investments, LP has filed 21 Form 4s with the SEC that we hold, for Rocket Pharmaceuticals, INC. (RCKT) (Director, 10% owner), Orchestra BioMed Holdings, Inc. (OBIO) (10% owner), RCOR (10% owner) and Allurion Technologies, INC. (ALUR) (10% owner), among 9 companies in all. Across all of them we count 12 purchases worth $51.3M and 4 sales worth $13.9M reported on Form 4. In the last 12 months: 1 purchase ($8.0M) and 1 sale ($132). The largest single trade was a purchase of 1,355,932 shares of Rocket Pharmaceuticals, INC. worth $20.0M, dated 2022-10-06. The first filing on our record is dated 2021-09-07 and the latest 2026-07-23.

Rocket Pharmaceuticals, INC. (RCKT)

Director, 10% owner · 6 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-10-06P, purchase reported on Form 41,355,932$20.0M2022-10-11

Orchestra BioMed Holdings, Inc. (OBIO)

10% owner · 5 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-04-29P, purchase reported on Form 450,000$126.5K2025-04-29
2026-04-27S, sale reported on Form 432$1322026-04-29

RCOR

10% owner · 4 filings · 8 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-02P, purchase reported on Form 4800,000$8.0M2021-09-07
2021-12-29P, purchase reported on Form 4479$3.8K2022-01-03
2021-12-30P, purchase reported on Form 43,743$29.9K2022-01-03
2022-01-03P, purchase reported on Form 4441$3.5K2022-01-03
2022-01-04P, purchase reported on Form 44$312022-01-06
2022-01-05P, purchase reported on Form 4100,195$801.6K2022-01-06
2022-01-06P, purchase reported on Form 451,296$410.4K2022-01-06
2022-01-18P, purchase reported on Form 444,440$355.5K2022-01-20

Allurion Technologies, INC. (ALUR)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

CRGX

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

DMTK

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-11-04S, sale reported on Form 4100,000$177.0K2022-11-08

Kailera Therapeutics, Inc. (KLRA)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-04-20P, purchase reported on Form 4500,000$8.0M2026-04-22

LABP

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-09-23S, sale reported on Form 4300,000$207.0K2022-09-27

Milestone Pharmaceuticals Inc. (MIST)

10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-09-07P, purchase reported on Form 41,557,346$13.6M2022-09-09
2022-09-07S, sale reported on Form 41,557,346$13.6M2022-09-09
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1493215) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms